MedTrace Logo

Lepticore in Metabolic Syndrome and Weight Loss

NCT01046968 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2010-01-12

No results posted yet for this study

Summary

Metabolic syndrome is directly related to obesity. This study investigated the use of a plant based formulation to improve on the condition of people with metabolic syndrome.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lepticore

300 mg twice daily

Sponsors & Collaborators

  • Cameroon Nutritional Science Society

    collaborator UNKNOWN

  • University of Yaounde 1

    lead OTHER

Principal Investigators

  • Julius E Oben, PhD · University of Yaounde 1

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
52 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01046968 on ClinicalTrials.gov